FOLH1 and prostate carcinoma: In a research study, polymeric micelles were conjugated with I-131-labeled prostate-specific membrane antigen (PSMA) antibody and demonstrated the co-delivery of miRNA and chemotherapeutic drugs to prostate cancer cells without any adverse effects [262].